Evoke Wealth’s Chembio diagnostics, Inc. CEMI Stock Holding History

Evoke Wealth’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-856	Closed	-$4K	–	1229
2020 Q4	$4K	Buy	+856	New	+$4.42K	﹤0.01%	801

Other funds holding CEMI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Evoke Wealth's CEMI Position: Q1 2021 in Review

Evoke Wealth sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2021, closing a stake of 856 shares — an estimated $4K sold.

Evoke Wealth first reported a position in CEMI in Q4 2020 and held it in 1 quarter. The position peaked at $4K in Q4 2020. 72 funds tracked by Wall St. Rank hold CEMI as of Q1 2021.

Evoke Wealth reported no remaining Chembio diagnostics, Inc. position as of Q1 2021 after selling out during the quarter.
Evoke Wealth sold 856 Chembio diagnostics, Inc. shares in Q1 2021, an estimated $4K.
Evoke Wealth first reported a position in Chembio diagnostics, Inc. in Q4 2020 and held it in 1 quarter.
Evoke Wealth's Chembio diagnostics, Inc. position peaked at $4K in Q4 2020.
72 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2021.

Based on Evoke Wealth's 13F filing for Q1 2021, filed 13 May 2021.